Shares of Sonova Holding (OTCMKTS:SONVY – Get Free Report) have received a consensus rating of “Hold” from the seven research firms that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, two have given a buy recommendation and one has assigned a strong buy recommendation to the company.
Several brokerages have issued reports on SONVY. Morgan Stanley upgraded Sonova from an “underweight” rating to an “equal weight” rating in a report on Tuesday, June 23rd. UBS Group upgraded Sonova from a “hold” rating to a “buy” rating in a report on Wednesday, July 22nd. Finally, Citigroup reiterated a “sell” rating on shares of Sonova in a research report on Friday, July 24th.
Read Our Latest Analysis on Sonova
Sonova Trading Up 0.8%
Sonova Company Profile
Sonova Holding AG is a Switzerland-based company focused on hearing care and hearing solutions. Through its businesses, the company develops, manufactures and distributes hearing aids, cochlear implants and other hearing-related technologies designed to help people with hearing loss communicate and participate more fully in daily life.
Sonova’s portfolio includes hearing instruments and accessories, wireless communication products, implantable hearing systems and audiological services.
Recommended Stories
- Five stocks we like better than Sonova
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.
